Near observation and frequent titration are warranted until discomfort administration is secure on the new opioid. Monitor patients for signs and indications of opioid withdrawal and for signs of oversedation/toxicity right after changing patients to OXYCONTIN.There have already been uncommon put up-internet marketing experiences of scenarios of in